Acquisition of resistance to Fas-mediated apoptosis by overexpression of clusterin in human renal-cell carcinoma cells

Molecular Urology

Volumn 5, Issue 3, 2001, Pages 105-111

  Miyake, Hideaki ^a   Hara, Shoji ^a   Kamidono, Sadao ^a   Hara, Isao ^a   Zellweger, Tobias ^b   Gleave, Martin E ^b  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLUSTERIN; FAS ANTIBODY; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL FRACTIONATION; CELL GROWTH; CONTROLLED STUDY; CYTOTOXICITY; EXPRESSION VECTOR; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; APOPTOSIS; CARCINOMA, RENAL CELL; CELL DIVISION; CLUSTERIN; CYTOTOXICITY, IMMUNOLOGIC; GLYCOPROTEINS; HUMANS; INTERFERONS; INTERLEUKIN-2; MOLECULAR CHAPERONES; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034856692     PISSN: 10915362     EISSN: None     Source Type: Journal    
DOI: 10.1089/10915360152559585     Document Type: Article

References (22)

1. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: A Swiss experience with 588 tumors
2. Novel investigative approaches for advanced renal cell carcinoma
3. Interleukin-2 in the treatment of renal cancer
4. Interferon in metastatic renal cell carcinoma
5. Purification and characterization of a cell-aggregating factor (clusterin), the major glycoprotein in ram rete testis fluid
6. Clusterin: Physiologic and pathophysiologic considerations
7. Prostatic ductal system in rats: Regional variation in localization of an androgen-repressed gene product, sulfated glycoprotein-2
8. SGP-2 expression as a genetic marker of progressive cellular pathology in experimental hydronephrosis
9. Lack of association between enhanced TRPM-2/clusterin expression and increased apoptotic activity in sex-hormone-induced prostatic dysplasia of the Noble rat
10. Clusterin protects against oxidative stress in vitro through aggregative and nonaggregative properties
11. Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen-independence in prostate cancer
12. Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models
13. Antisense TRPM-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells both in vitro and in vivo
14. Gp80 (clusterin; TRPM-2) mRNA levels is enhanced in human renal clear cell carcinomas
15. Fas-induced apoptosis, and disease caused by its abnormality
16. Anti-Fas on nonhematopoietic tumors: Levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness
17. Fas and Fas ligand in embryos and adult mice: Ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover
18. Frequent expression of bcl-2 in renal-cell carcinomas carrying wild-type p53
19. Fas/Apo-1-mediated apoptosis of human renal cell carcinoma
20. p53 modulation of Fas/Apo-1 mediated apoptosis in a human renal cell carcinoma cell line
21. Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidyl 3′-kinase pathway
22. Induction Fas-mediated apoptosis in p53-transfected human colon carcinoma cells